Skip to main content
Measurement-based care is one of the few process changes in psychotherapy with a sustained evidence base behind it. Practitioners who administer validated outcome measures consistently — and who actually look at the results between sessions — detect deterioration earlier and adjust treatment sooner than practitioners who rely on impression alone.

​
The Lambert program

Michael J. Lambert and colleagues at Brigham Young University ran the foundational program of research on routine outcome monitoring. Across multiple large clinical trials, they found that giving therapists a session-by-session feedback signal about whether each client was on or off the expected response trajectory:
  • Reduced the rate of clients who deteriorated by the end of treatment
  • Roughly doubled the rate of clinically significant improvement for clients who were predicted to be “not on track”
  • Made the largest difference for the clients clinicians were most likely to miss on impression alone — the ones quietly drifting
Key references:
  • Lambert, M. J., Whipple, J. L., & Kleinstäuber, M. (2018). “Collecting and delivering progress feedback: A meta-analysis of routine outcome monitoring.” Psychotherapy, 55(4), 520–537.
  • Lambert, M. J., et al. (2003). “Is it time for clinicians to routinely track patient outcome? A meta-analysis.” Clinical Psychology: Science and Practice, 10(3), 288–301.

​
Boswell and colleagues — why it doesn’t always stick

James F. Boswell and colleagues have written extensively about why MBC works clinically but doesn’t always get adopted in real practices. Their work identifies the practical barriers and what addresses them:
  • Boswell, J. F., Kraus, D. R., Miller, S. D., & Lambert, M. J. (2015). “Implementing routine outcome monitoring in clinical practice: Benefits, challenges, and solutions.” Psychotherapy Research, 25(1), 6–19.
Their conclusions, summarized:
  • MBC works clinically. The evidence base is strong enough that it appears in APA, NICE, and SAMHSA guidance.
  • The most common adoption failures are workflow failures, not clinical ones — long forms, async homework that doesn’t come back, separate systems for measures and notes, no clear way to surface the result inside the session.
  • The adoption pattern that does stick is the one where measures are administered consistently (intake, every 2–4 sessions, discharge) and the result is in front of the practitioner immediately.

​
What this means for your practice

Three practical implications: Pick a small, consistent battery. PHQ-9 for depression, GAD-7 for anxiety, plus whatever specific measure fits the presenting concern (PCL-5 for trauma, ISI for sleep, AUDIT for alcohol, K10 as a general distress check). The benefit comes from administering the same measure the same way, not from breadth. Administer at known intervals. Intake. Every 2–4 sessions during treatment. Discharge. This is the rhythm the research uses — and it’s the rhythm that catches non-response before it’s entrenched. Look at the score during the session. Not after. The conversation about a worsening PHQ-9 is the intervention. A score sitting in a chart folder until the following week is not the intervention.

​
What the research does not say

A few honest limits on the literature:
  • MBC doesn’t replace clinical judgment. The score is one input among many.
  • The size of the effect is modest at the level of the average client, and much larger for the subgroup who would otherwise deteriorate. The population benefit is concentrated in the clients you’d most want to catch early.
  • Most of the trials use the OQ-45 or PCOMS (ORS/SRS) as the tracking measure. The PHQ-9 / GAD-7 / PCL-5 evidence is from outcome studies on the measures themselves rather than from MBC trials specifically — the generalization to those scales is reasonable but not identical.

Administering measures in session

The collaborative fill flow that puts the score in front of you while you can still talk about it.

Clinical change thresholds

What counts as meaningful improvement on the measures you’ll use most.